Antegrin Therapeutics secures investment from i6 Project - MarketLine Financial Deals

Antegrin Therapeutics secures investment from i6 Project

Antegrin Therapeutics secures investment from i6 Project - MarketLine Financial Deals
Antegrin Therapeutics secures investment from i6 Project
Published Apr 02, 2013
1 pages — Published Apr 02, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Antegrin Therapeutics, a US-based developer of small molecule integrin antagonists for use in multiple disease states, has secured investment

  
Source:
Document ID
MA138986_130517
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Antegrin Therapeutics secures investment from i6 Project" Apr 02, 2013. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Antegrin-Therapeutics-secures-investment-from-i6-Project-2052-94536>
  
APA:
MarketLine Financial Deals. (2013). Antegrin Therapeutics secures investment from i6 Project Apr 02, 2013. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Antegrin-Therapeutics-secures-investment-from-i6-Project-2052-94536>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.